查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1866535

造影注射器市场－2025-2030年预测

Contrast Injector Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

造影注射器市场预计将从 2025 年的 15.56 亿美元成长到 2030 年的 22.06 亿美元，复合年增长率为 7.24%。

造影注射器市场是医学影像领域的基础性组成部分，它能够精准地註射造影剂，从而提高CT、MRI和血管造影术等检查的影像清晰度。这些自动化系统可以控製造影剂的用量，最大限度地降低风险，并优化放射科、介入心臟科和神经科的诊断效果。在影像检查和技术融合的推动下，以及医疗界对慢性疾病早期检测日益重视的推动下，该市场持续扩张。然而，高成本和复杂的监管环境正在限制其成长，尤其是在新兴地区。

本分析检验了当前及近期需求、供应和销售趋势，深入分析了驱动因素、阻碍因素和机会，包括区域政策和法规。它分析了以FDA和EMA等监管机构为主导的监管环境，并指出了影响市场动态的因素。

我们的竞争情报分析主要企业及其对营收的影响。分析基于二手资料研究，涵盖协会调查、分析师报告、投资者报告、新闻稿和学术期刊。我们的市场规模估算采用由下而上和自上而下相结合的方法，并辅以价值链相关人员的意见。我们的市场分析整合了多个数据来源和专有数据，从而建立稳健的分析和预测。

透过叙述、图表和图形来传达洞察，以便更清晰地了解市场。 2024年，该市值约为20.8亿美元，预计2025年将达22.4亿美元，到2030年将成长至37.5亿美元，复合年增长率为10.87%。主要细分市场包括注射器系统（单头、双头、无针注射器）和耗材，其中放射学应用占据主导地位，2024年市场份额将达到45.47%。

主要亮点

慢性疾病（包括心血管疾病和癌症）的日益增多，推动了对使用造影进​​行诊断影像的需求。非传染性疾病（NCDs）占全球死亡人数的71%。具备剂量优化功能的AI驱动注射器可提高安全性和效率。预计到2050年，65岁以上人口将达到15亿，老龄化人口将随之增加，诊断需求也随之增加。然而，高昂的设备成本（高级型号超过5万美元）限制了其在资源匮乏地区的普及应用。

成长要素

慢性病流行（每年有1790万人死于心血管疾病）导致人们对诊断影像的依赖性日益增强。人工智慧预测剂量等创新技术（可减少20%的浪费）将简化工作流程。人口结构变化将推动检查量增加，预计到2024年，老年影像检查量将增加12%。微创手术量到2025年将成长15%，这需要精准的输液设备。

抑制因素

高昂的实施和维修成本是广泛应用的一大障碍，尤其是在低收入地区，超过50%的患者无法获得放射科服务。严格的FDA/EMA核准流程延缓了产品上市，而造影剂造影的风险，例如肾毒性，进一步加剧了这个问题。发展中地区基础设施的匮乏也限制了其应用。

細項分析

按产品类型划分：注射器系统因其与CT/MRI的兼容性主导。与频繁操作相关的耗材将成为成长最快的产品。

按技术划分：旨在减少错误并整合人工智慧的自动注射器是主流，占市场份额的 60% 以上。

按应用领域划分：放射科占 45.47%，这主要归因于 CT/MRI 检查的激增，介入性心臟病学也在加速发展。

按最终用户划分：医院和诊所占 68.37%，这得益于基础设施投资。

区域分析

北美地区将持续保持领先地位，预计2024年将占据38.87%的市场。在慢性病负担日益加重和技术创新推动下，预计到2025年，北美市场规模将达到8.7249亿美元（年复合成长率为9.69%）。亚太地区将成为成长最快的地区，年复合成长率为8.5%，主要得益于中国和印度医疗保健产业的扩张。欧洲市场将因人口老化和监管支持而保持稳定成长。

重大进展

2025 年初，GE 医疗与一家人工智慧公司合作开发了一种具有预测分析功能的注射器，用于个人化 CT/血管造影术的药物剂量；2024 年，Bracco 推出了环保型「Max 3™」无针 MRI 注射器，透过可回收组件减少废弃物。

本报告为专业人士提供了关于趋势、法规和竞争格局的实用见解，重点阐述了人工智慧和永续性领域在成本壁垒下所蕴含的机会。报告采用基于一手和二手数据的严谨调查方法，得出可靠的预测，为投资决策提供支持，而投资决策对于该领域的诊断至关重要。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 以注射器类型造影的造影剂注射器市场

  • 介绍
  • 单头喷油器
  • 双头喷油器
  • 无针注射器

第六章 依应用造影注射器市场

  • 介绍
  • 放射医学
  • 介入放射学
  • 介入性心臟病学

第七章 依最终使用者造影的显影剂注射器市场

  • 介绍
  • 医院和诊所
  • 诊断中心
  • 门诊手术中心
  • 诊所、研究机构

第八章 各地区造影注射器市场

  • 介绍
  • 北美洲
    • 按喷油器类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按喷油器类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 按喷油器类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 英国
      • 德国
      • 法国
      • 义大利
      • 其他的
  • 中东和非洲
    • 按喷油器类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 按喷油器类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 台湾
      • 其他的

第九章：竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • Bayer AG
  • Bracco Imaging SpA
  • Guerbet SA
  • Medtron AG
  • Ulrich GmbH & Co. KG
  • GE Healthcare
  • Nemoto Kyorindo Co., Ltd.
  • Medtronic plc
  • AngioDynamics, Inc.
  • Hilin Life Products, Inc.
  • Apollo RT Co. Ltd.
  • Vivid Imaging
  • Sino Medical-Device Technology Co., Ltd.

第十一章 分析方法

简介目录
Product Code: KSI061611961

The Contrast Injector Market is expected to grow from USD 1.556 billion in 2025 to USD 2.206 billion in 2030, with a 7.24% CAGR.

The contrast injector market is a cornerstone of medical imaging, facilitating precise administration of contrast agents to enhance visibility in CT, MRI, and angiography procedures. These automated systems deliver controlled volumes of media, minimizing risks and optimizing diagnostic outcomes in radiology, interventional cardiology, and neurology. With healthcare's emphasis on early detection of chronic conditions, the market is expanding, propelled by rising imaging volumes and technological integration. However, high costs and regulatory complexities temper growth, particularly in emerging regions.

This analysis explores current demand, supply, and sales trends, alongside recent developments. It delivers a thorough examination of drivers, restraints, and opportunities, including regional policies and regulations. The regulatory landscape, governed by bodies like the FDA and EMA, is dissected to illuminate factors shaping market dynamics.

Competitive intelligence profiles key players and their revenue impacts, sourced from secondary research encompassing association studies, analyst reports, investor materials, press releases, and journals. Market sizing for the sector and segments employs bottom-up and top-down methods, corroborated by stakeholder inputs from the value chain. Market engineering consolidates multi-source data and proprietary datasets via triangulation for robust breakdowns and projections.

Insights are conveyed through narratives, charts, and graphics for streamlined market comprehension. The market, valued at approximately USD 2.08 billion in 2024, is projected to reach USD 2.24 billion in 2025, growing at a CAGR of 10.87% to USD 3.75 billion by 2030. Key segments include injector systems (single-head, dual-head, syringeless) and consumables, with radiology applications dominating at 45.47% share in 2024.

Key Highlights

Rising chronic diseases, including cardiovascular conditions and cancer, escalate demand for contrast-enhanced imaging, with NCDs causing 71% of global deaths. AI-driven injectors with dose optimization boost safety and efficiency. An aging population, projected to hit 1.5 billion over 65 by 2050, heightens diagnostic needs. High equipment costs, exceeding $50,000 for advanced models, constrain adoption in resource-limited settings.

Growth Drivers

Chronic disease prevalence, with cardiovascular issues claiming 17.9 million lives yearly, drives imaging reliance. Technological innovations, like AI for predictive dosing reducing waste by 20%, streamline workflows. Demographic shifts amplify procedure volumes, with a 12% rise in elderly imaging noted in 2024. Minimally invasive procedures, up 15% in 2025, favor precise injectors.

Restraints

Elevated costs for acquisition and maintenance hinder penetration, especially in low-income areas where over 50% lack radiology services. Stringent FDA/EMA approvals delay launches, compounded by contrast-related risks like nephrotoxicity. Infrastructure deficits in developing regions limit access.

Segmentation Analysis

By Product: Injector systems lead, driven by CT/MRI compatibility; consumables grow fastest with high procedure volumes.

By Technology: Automated injectors prevail for error reduction and AI integration, holding over 60% share.

By Application: Radiology commands 45.47% due to CT/MRI surges, with interventional cardiology accelerating.

By End-User: Hospitals & clinics dominate at 68.37%, fueled by infrastructure investments.

Regional Analysis

North America leads with 38.87% share in 2024, bolstered by chronic disease burdens and innovations, projecting USD 872.49 million in 2025 at 9.69% CAGR. Asia Pacific grows fastest at 8.5% CAGR, driven by healthcare expansions in China and India. Europe sustains steady growth via aging demographics and regulatory support.

Key Developments

In early 2025, GE HealthCare partnered with an AI firm for predictive analytics-enabled injectors, personalizing CT/angiography dosing. In 2024, Bracco launched the eco-friendly Max 3(TM) syringeless MRI injector, reducing waste via recyclable components.

This report arms experts with actionable intelligence on trends, regulations, and competition. It spotlights opportunities in AI and sustainability amid cost hurdles. Methodological rigor from primary/secondary data yields dependable projections, aiding navigation of investments in this diagnostics linchpin.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Injector Type

  • Single-Head Injector
  • Dual-Head Injectors
  • Syringeless Injector

By Application

  • Radiology
  • Intervention radiology
  • Intervention cardiology

By End-User

  • Hospitals & Clinics
  • Diagnostic Centres
  • Ambulatory Surgical Centres
  • Clinics and Research Institutes

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CONTRAST INJECTOR MARKET BY INJECTOR TYPE

  • 5.1. Introduction
  • 5.2. Single-Head Injector
  • 5.3. Dual-Head Injectors
  • 5.4. Syringeless Injector

6. CONTRAST INJECTOR MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Radiology
  • 6.3. Intervention radiology
  • 6.4. Intervention cardiology

7. CONTRAST INJECTOR MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Diagnostic Centres
  • 7.4. Ambulatory Surgical Centres
  • 7.5. Clinics and Research Institutes

8. CONTRAST INJECTOR MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Injector Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Injector Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Injector Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Others
  • 8.5. Middle East & Africa
    • 8.5.1. By Injector Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Injector Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Bayer AG
  • 10.2. Bracco Imaging S.p.A.
  • 10.3. Guerbet S.A.
  • 10.4. Medtron AG
  • 10.5. Ulrich GmbH & Co. KG
  • 10.6. GE Healthcare
  • 10.7. Nemoto Kyorindo Co., Ltd.
  • 10.8. Medtronic plc
  • 10.9. AngioDynamics, Inc.
  • 10.10. Hilin Life Products, Inc.
  • 10.11. Apollo RT Co. Ltd.
  • 10.12. Vivid Imaging
  • 10.13. Sino Medical-Device Technology Co., Ltd.

11. RESEARCH METHODOLOGY